Disposition of 1597 shares by Aguilar-cordova Estuardo of Candel Therapeutics at 5.8 subject to Rule 16b-3

SQZDelisted Stock  USD 0.10  0.04  28.57%   
Slightly above 62% of Sqz Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Sqz Biotechnologies Co suggests that many traders are alarmed regarding Sqz Biotechnologies' prospects. Sqz Biotechnologies' investing sentiment can be driven by a variety of factors including economic data, Sqz Biotechnologies' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Candel Therapeutics 10 Percent Owner. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1597 cadl at 5.8 of Candel Therapeutics by Aguilar-cordova Estuardo on 25th of October 2024. This event was filed by Candel Therapeutics with SEC on 2024-10-25. Statement of changes in beneficial ownership - SEC Form 4

Sqz Biotechnologies Fundamental Analysis

We analyze Sqz Biotechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Earnings To Growth

Price To Earnings To Growth Comparative Analysis

Sqz Biotechnologies is currently under evaluation in price to earnings to growth category among its peers. PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

Sqz Biotechnologies Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sqz Biotechnologies stock to make a market-neutral strategy. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics with similar companies.

Peers

Sqz Biotechnologies Related Equities

ANTXAN2 Therapeutics   21.90   
0%
100.0%
PCSAProcessa Pharmaceuticals   18.37   
0%
83.0%
MNPRMonopar Therapeutics   8.84   
0%
40.0%
IKTInhibikase Therapeutics   6.96   
0%
31.0%
LIPOLipella Pharmaceuticals   5.42   
0%
24.0%
QNRXQuoin Pharmaceuticals   1.69   
0%
7.0%
HOWLWerewolf Therapeutics   1.52   
0%
6.0%
PMVPPmv Pharmaceuticals   1.25   
0%
5.0%
KZRKezar Life   0.95   
0%
4.0%
SNTISenti Biosciences   0.93   
0%
4.0%
FENCFennec Pharmaceuticals   0.83   
0%
3.0%
ANEBAnebulo Pharmaceuticals   0.70   
0%
3.0%
NUVBNuvation Bio   0.35   
0%
1.0%
SABSSAB Biotherapeutics   1.02   
4.0%
0%
THRDThird Harmonic   2.67   
12.0%
0%
CADLCandel Therapeutics   4.85   
22.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Sqz Stock

If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world